Last update 01 Nov 2024

Mitsubishi Tanabe Pharma Korea Co., Ltd.

Subsidiary Company|
Seoul, South Korea

Overview

Tags

Respiratory Diseases
Congenital Disorders
Nervous System Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Endocrinology and Metabolic Disease1
Hemic and Lymphatic Diseases1
Nervous System Diseases1
Top 5 Drug TypeCount
Small molecule drug2
Top 5 TargetCount
H3 receptor(Histamine H3 receptor)1
HIF-PHs(Hypoxia-inducible factor prolyl hydroxylase)1

Related

2
Drugs associated with Mitsubishi Tanabe Pharma Korea Co., Ltd.
Vadadustat
Target
HIF-PHs
Mechanism
HIF-PHs inhibitors
Active Org.
Adjutor Healthcare Pty Ltd.Adjutor Healthcare Pty Ltd.Startup [+4]
Originator Org.
Akebia Therapeutics, Inc.Akebia Therapeutics, Inc.
Active Indication
Anemia in chronic kidney disease [+5]
Inactive Indication
Liver Diseases [+1]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
JP
First Approval Date29 Jun 2020
Pitolisant Hydrochloride
Target
H3 receptor
Mechanism
H3 receptor antagonists
Active Org.
Bioprojet Pharma SARLBioprojet Pharma SARL [+5]
Originator Org.
Bioprojet Pharma SARLBioprojet Pharma SARL
Active Indication
Excessive Daytime Sleepiness [+6]
Inactive Indication
Alcohol Use Disorder [+6]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
EU [+3]
First Approval Date31 Mar 2016
1
Clinical Trials associated with Mitsubishi Tanabe Pharma Korea Co., Ltd.
KCT0004667 / CompletedPhase 1
A double-blind, placebo-controlled, clinical pharmacology study to investigate the safety, tolerability and pharmacokinetics of single and multiple doses of MT-5199 in healthy male Korean subjects
100 Clinical Results associated with Mitsubishi Tanabe Pharma Korea Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Mitsubishi Tanabe Pharma Korea Co., Ltd.
Login to view more data
100 Deals associated with Mitsubishi Tanabe Pharma Korea Co., Ltd.
Login to view more data
100 Translational Medicine associated with Mitsubishi Tanabe Pharma Korea Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 25 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Pitolisant Hydrochloride
 ( H3 receptor )		Narcolepsy
More
Approved
Vadadustat
 ( HIF-PHs )		Chronic Kidney Diseases
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free